Grünenthal Group, a pharmaceutical company based in Germany, announced a collaboration with Proteus S.A., a Chilean company, and Boston Children’s Hospital on the anesthetic neosaxitoxin. Neosaxitoxin is a novel anesthetic used for local anesthesia and post-operative pain management.